Maravai LifeSciences Holdings, Inc.
MRVIBiotechnology
$8.46−0.47%As of Oct 29vs prior close
- Market cap
- $3.1B
- P/E (TTM)
- –
- From 52W high
- −6.00%
- EPS (LTM)
- -$0.52
- Revenue (LTM)
- $208.8M
- Net margin
- -37.07%
Nomior Score
60
Emerging BreakoutSpeculativeTop 26% of the scored universe
Growth46
Quality50
Value57
Momentum97
Resilience34
Growth
+4.44%revenue a year over 6 fiscal years
YE19 $143.1MLTM $208.8M
Connections
Revenue to profitQ2 YE26
The operating loss was 29% of revenue, narrower by 111 pts on a year.
Who owns it
2funds, 2 tracked portfolios